Skip to main content
OpenTrials
Completed

NCT Number: NCT04789213

Mortality, Morbidity and Risk Factors of Liver Retransplantation

This study aims to compare the short and long term outcomes of living donor and deceased donor liver retransplantation. Bearing that in mind, the investigators will retrospectively analyze the files of patients whom underwent a liver retransplantation in Memorial Bahcelievler Hospital Organ Transplantation Center.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liver Transplant; Complications Behavior Digestive System Diseases Fibrosis Hepatic Insufficiency Liver Cirrhosis Liver Diseases Liver Failure Liver Transplant Failure Liver Transplant Rejection Organ Transplant Failure or Rejection Pathologic Processes Pathological Conditions, Signs and Symptoms Rejection, Psychology Social Behavior

Age range

0 month and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Memorial Bahçelievler Hospital

Istanbul, 34700, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having a liver retransplantation

Exclusion criteria

  • N/A

Treatment and study plan

Liver transplantation

Other

Liver Transplantation

Primary outcomes

  1. Survival ratio

    Time frame: 1 minutes

    Overall graft and patient survival ratio

Secondary outcomes

  1. Morbidity

    Time frame: 10 minutes

    Postoperative complications such as septicemia, hepatic artery thrombosis etc.

  2. Peri-operative informations

    Time frame: 15 minutes

    Peri-operative informations such as blood loss during surgery

  3. Blood Test Results

    Time frame: 20 minutes

    Patients' blood test results specific to liver such as International Normalization Ratio

Sponsors and collaborators

Lead sponsor

Memorial Bahçelievler Hospital

Other

Registry information

Official study title

Comparison of Mortality, Morbidity and Risk Factors in Living- Donor and Deceased-Donor Liver Retransplantation

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Mar 9, 2021
Registry last updated
Dec 6, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.